Fact-checked by Grok 2 weeks ago

Polymenorrhea

Polymenorrhea is a type of defined by menstrual cycles occurring at intervals of less than 24 days, in contrast to the normal range of 24 to 38 days. This condition involves regular but frequent periods, with typical menstrual flow volume and duration, distinguishing it from disorders like menorrhagia, which features excessive bleeding. Polymenorrhea affects approximately 5-10% of reproductive-age women. Polymenorrhea often arises from disruptions in the hormonal regulation of the and may be associated with structural or nonstructural uterine abnormalities under the FIGO PALM-COEIN classification system. involves clinical history, tests, and , while management focuses on addressing underlying causes with hormonal therapies or other interventions as needed. Early evaluation is important to prevent complications such as .

Definition and Characteristics

Definition

Polymenorrhea is defined as a menstrual disorder characterized by cycles occurring at intervals of less than 24 days from the onset of one period to the next. This condition involves regular but abnormally frequent menstruation, distinguishing it from irregular bleeding patterns. In contrast to the normal menstrual cycle, which typically ranges from 24 to 38 days in length for reproductive-age adults, polymenorrhea results in shortened intervals that disrupt the standard rhythm. Earlier guidelines, such as those from ACOG in 2015, considered 21 to 45 days normal for adolescents. Menstrual cycle length is measured by counting the number of days from the first day of menstrual bleeding (day 1) to the first day of the subsequent period, excluding the length of bleeding itself. The term polymenorrhea originates from the roots "poly," meaning many, and "menorrhea," derived from "mēn" (month or ) and "rhoia" (flow), reflecting its association with frequent monthly bleeding. It has been part of gynecological terminology since the early , evolving alongside classifications of menstrual irregularities in medical texts. In the FIGO classification system for , polymenorrhea corresponds to frequent menstrual bleeding (denoted as "F"). Polymenorrhea is characterized by menstrual cycles shorter than 24 days, with bleeding that is typically normal in volume and duration but occurs at increased frequency, distinguishing it from other menstrual irregularities that primarily involve alterations in bleeding volume, pattern, or absence. In contrast, (formerly menorrhagia or hypermenorrhea) focuses on excessive blood loss (>80 mL) or prolonged duration (>8 days) during otherwise regular cycles, while (formerly metrorrhagia) involves unscheduled bleeding outside of menstrual periods, and amenorrhea and oligomenorrhea pertain to reduced or absent frequency. This frequency-based classification of polymenorrhea aids in avoiding diagnostic overlap, as it emphasizes cycle interval over quantity or timing irregularities seen in volume- or pattern-based conditions. The following table summarizes key distinctions:
DisorderDefining FeatureCycle LengthBleeding Characteristics
PolymenorrheaIncreased frequency of cycles<24 daysNormal volume and duration
OligomenorrheaInfrequent cycles>38 daysNormal volume and duration
AmenorrheaAbsence of menstruationNone (≥3 months)No bleeding
Heavy or prolonged menstrual bleedingNormal (24-38 days)Excessive volume (>80 mL) or duration (>8 days), normal frequency
Irregular bleeding between cyclesVariableUnscheduled, often light to moderate
In the , 11th Revision (), polymenorrhea is classified under code .10 for frequent menstrual bleeding, within the broader category of bleeding disorders (GA20), highlighting its basis in abnormal cycle regularity rather than volume or intermenstrual patterns.

Causes

Physiological Causes

Polymenorrhea in adolescents often arises from the immaturity of the hypothalamic-pituitary-ovarian (HPO) axis, which typically leads to anovulatory cycles during the first few years following . In girls aged 10-15, the HPO axis is not fully developed, resulting in irregular and unstable endometrial growth due to unopposed exposure without the stabilizing effect of progesterone. This can manifest as shortened menstrual cycles of less than 21 days, as the lack of disrupts the normal follicular and luteal phases, causing frequent but unpredictable bleeding. Such patterns are considered physiological and self-resolving, with up to 50% of cycles remaining anovulatory in the initial postmenarchal years, though normalization occurs in 60-80% of cases by the third year. During perimenopause, typically affecting women aged 40-50, declining ovarian function and erratic production contribute to hormonal fluctuations that shorten menstrual cycles. As follicle numbers diminish, levels become inconsistent, leading to less frequent and altered cycle lengths, often reducing from the typical 28 days to as short as or less. This phase involves rising and falling alongside reduced progesterone, which destabilizes the and results in more frequent periods, sometimes varying by seven days or more between cycles. These changes are a natural transition toward , with shorter cycles more common early in perimenopause before periods become skipped or prolonged. Postpartum and periods can also trigger polymenorrhea through the effects of on the HPO axis, particularly during the transition after . During , elevated from frequent nursing suppresses (GnRH) and , delaying menses for 3-6 months or longer in fully breastfeeding women. Upon , levels drop, allowing the HPO axis to reactivate, which may initially cause irregular cycles, including frequent menstruation as resumes unpredictably. This physiological rebound can lead to shortened cycles in the months following , as the readjusts from the suppressive state. Acute emotional or physical represents another physiological factor in polymenorrhea by interfering with GnRH pulsatility in the , thereby shortening the of the . activates the hypothalamic-pituitary-adrenal , elevating , which inhibits the normal pulsatile release of GnRH and disrupts downstream secretion, leading to ovulatory dysfunction and shortening to under 21 days. This effect is typically transient and resolves with stress reduction, as the HPO regains , but repeated episodes can contribute to ongoing irregularities.

Pathological Causes

Pathological causes of polymenorrhea encompass a range of underlying medical conditions that disrupt the normal hormonal regulation, structural integrity, or hemostatic mechanisms of the , leading to shortened intervals between periods (typically less than 21 days). These etiologies often result in chronic or recurrent symptoms requiring medical intervention, distinguishing them from transient physiological triggers. Endocrine disorders, structural uterine abnormalities, bleeding disorders, iatrogenic factors, and infections represent key categories implicated in this condition. Endocrine Disorders
Endocrine imbalances frequently contribute to polymenorrhea by altering secretion, patterns, or estrogen-progesterone dynamics. , characterized by elevated thyroid hormone levels, typically causes oligomenorrhea or amenorrhea through increased and testosterone production, which enhances peripheral conversion of androgens to estrone, thereby disrupting follicular and luteal phases; however, menstrual irregularities can include polymenorrhea in a subset of cases. (PCOS), involving irregular due to elevated (LH) and androgens with prolonged unopposed estrogen exposure, typically manifests as oligomenorrhea but can present with polymenorrhea in patients exhibiting erratic ovulatory patterns that lead to frequent endometrial shedding. Hyperprolactinemia, often resulting from prolactinomas or medication-induced elevation, inhibits (GnRH) and LH pulsatility, suppressing consistent and causing polymenorrhea alongside oligomenorrhea or in affected individuals. These disruptions highlight the role of the hypothalamic-pituitary-ovarian axis in cycle regulation, with polymenorrhea reflecting anovulatory or shortened phases.
Structural Uterine Issues
Structural abnormalities within the can mechanically or hormonally interfere with endometrial buildup and shedding, promoting more frequent bleeding episodes. Uterine fibroids (leiomyomas), particularly submucosal ones, distort the endometrial cavity and increase vascularity, which may accelerate endometrial proliferation and result in polymenorrhea, often compounded by menorrhagia. Endometrial polyps, benign overgrowths of glandular tissue, similarly disrupt the uniformity of the endometrial lining, leading to irregular and shortened cycle intervals through focal bleeding or altered hormonal responsiveness. These lesions contribute to polymenorrhea by creating asynchronous endometrial responses to hormonal signals, potentially exacerbating blood loss over time.
Bleeding Disorders
Hematologic conditions impairing coagulation can contribute to (AUB), which may include irregular patterns such as shortened cycle intervals in some cases, though typically manifesting as . (vWD), the most common inherited bleeding disorder, reduces and activity, leading to defective platelet adhesion and excessive uterine bleeding due to inadequate during endometrial sloughing. Platelet dysfunction, whether congenital or acquired (e.g., from medications or ), similarly prolongs and can contribute to irregular bleeding patterns in AUB by allowing prolonged or heavy menses. These disorders are particularly relevant in adolescents and young women, where undiagnosed accounts for a significant proportion of abnormal uterine bleeding patterns.
Iatrogenic Causes
Medications and medical interventions can induce polymenorrhea as an by altering endometrial stability or vascular integrity. Progestin-only hormonal contraceptives, such as pills or implants, often provoke bleeding through a high progesterone-to-estrogen , which destabilizes the and leads to frequent, irregular withdrawal-like episodes resembling polymenorrhea. Intrauterine devices (IUDs), especially non-hormonal types, may cause local and increased endometrial fragility, resulting in shortened cycles or intermenstrual spotting that manifests as polymenorrhea. Anticoagulants, like or direct oral agents, exacerbate this by impairing clotting, turning typical menses into more frequent bleeding events in susceptible individuals. Discontinuation or adjustment of these agents is often necessary to resolve symptoms.
Infections and Inflammation
Infectious or inflammatory processes in the pelvic region can perturb cycle regularity by damaging endometrial tissue or inducing chronic inflammation. (PID), typically ascending infections from sexually transmitted pathogens like or , leads to polymenorrhea through tubal and endometrial scarring that disrupts ovulatory timing and promotes irregular shedding. , an inflammation of the endometrium often secondary to PID or postpartum infection, causes frequent bleeding by altering the endometrial response to hormones, resulting in shortened cycles and potential chronicity if untreated. Antibiotic therapy targeting the underlying infection is crucial to restore normal cyclicity.

Signs and Symptoms

Primary Menstrual Symptoms

Polymenorrhea is defined by menstrual occurring at intervals of less than 21 days, in contrast to the typical range of 21 to 35 days. This shortened length results in more frequent , often exceeding 17 periods per year compared to the range of approximately 10 to 17. The menstrual flow in polymenorrhea is typically of volume, ranging from 20 to 80 milliliters per cycle, though it may vary and present as lighter or heavier in some cases. Despite the increased frequency, cycles in polymenorrhea often maintain a degree of regularity in timing, differing from more chaotic irregularities seen in other disorders. This predictable yet frequent pattern can lead to greater use of sanitary products and disruptions in daily routines, such as work or social activities.

Secondary Associated Symptoms

Polymenorrhea, characterized by menstrual cycles shorter than , can lead to significant blood loss over time, increasing the risk of . Common symptoms of this include persistent , pallor of the skin, dizziness upon standing, and during mild activity, as the body struggles to maintain adequate counts. These effects arise from the cumulative impact of repeated bleeding episodes, which deplete iron stores faster than they can be replenished through diet alone. In addition to , individuals with polymenorrhea may experience heightened pain and discomfort associated with the more frequent menstrual events. , or painful menstrual cramps, can be intensified due to the shorter intervals between cycles, leading to recurrent lower that disrupts daily activities. Similarly, —mid-cycle pain—may become more noticeable or frequent in shortened cycles, presenting as sharp, one-sided pelvic aches around the time of . These pain symptoms often stem from underlying structural or ovulatory issues contributing to the condition. Hormonal fluctuations from irregular, frequent cycles can manifest in various and progesterone-related effects, such as mood swings, , and increased anxiety, which disrupt emotional stability. Breast tenderness and flares are also reported, as unstable levels affect glandular tissues and sebum production. These symptoms reflect the body's challenge in achieving hormonal equilibrium with reduced luteal phases between cycles. General accompanying polymenorrhea often includes headaches, sleep disturbances, and reduced , linked to the ongoing hormonal instability and physical toll of frequent bleeding. Fatigue from exacerbates these issues, contributing to overall feelings of lethargy and diminished . While these symptoms vary in severity, they underscore the systemic impact of cycle disruptions.

Diagnosis

Clinical Evaluation

The clinical evaluation of polymenorrhea begins with a comprehensive assessment to characterize the menstrual irregularity and identify potential underlying causes, emphasizing history-taking and as foundational steps. This approach helps differentiate polymenorrhea—defined as menstrual cycles shorter than 21 days—from other forms of and guides further investigation. Medical history taking is central, starting with a detailed menstrual to track cycle length, duration, and flow patterns over at least , often facilitated by patient diaries or mobile applications for accuracy. Inquiry extends to family history of or endocrine disorders, sexual and reproductive history including contraceptive use and pregnancies, and factors such as and patterns that may influence ovulatory function. Risk factor assessment involves targeted questions about recent stressors, which can disrupt hypothalamic-pituitary-ovarian axis regulation; excessive exercise or athletic training; significant weight changes, either gain or loss; and use, including hormonal therapies or anticoagulants that might shorten cycle intervals. These elements provide context for physiological versus pathological etiologies. The includes a general assessment for signs of systemic conditions, such as thyroid enlargement suggestive of or and indicating from chronic blood loss. A is performed to evaluate for uterine abnormalities like fibroids or polyps, involving speculum inspection and bimanual palpation to detect tenderness or masses. In the differential diagnosis framework, must be excluded early through menstrual and sexual history, supplemented by an initial or (hCG) test, as it can mimic polymenorrhea.

Diagnostic Tests

Laboratory tests form the cornerstone of diagnosing the underlying causes of polymenorrhea, beginning with blood analyses to evaluate hormonal, hematologic, and systemic factors. Hormone panels typically include measurements of (FSH), (LH), , and progesterone to assess ovulatory status and detect disruptions in the hypothalamic-pituitary-ovarian axis. These tests are ideally timed—FSH, LH, and on cycle day 2-5, and progesterone in the mid- (around day 21)—to identify or defects commonly associated with shortened cycles. , such as (TSH) and free thyroxine (T4), are recommended to rule out , which can accelerate menstrual cycles. A (CBC) is routinely performed to detect resulting from frequent blood loss, while studies—including , , and assays—are indicated if heavy bleeding accompanies the short cycles, to exclude inherited bleeding disorders. Imaging studies provide structural evaluation of the reproductive organs. Transvaginal ultrasound is the first-line imaging modality, offering high-resolution visualization to identify uterine fibroids, endometrial polyps, or ovarian cysts that may contribute to polymenorrhea by altering cycle regularity. If ultrasound findings are inconclusive or suggest focal lesions, may be employed for direct endoscopic inspection of the endometrial cavity, allowing for targeted if abnormalities are observed. Invasive procedures like are reserved for higher-risk cases to exclude or malignancy. This sampling technique is particularly recommended for women over 45 years old or those with risk factors such as , , or unopposed exposure, as these increase the likelihood of proliferative endometrial changes. Specialized tests address less common etiologies. levels are measured via serum assay if symptoms suggest pituitary involvement, such as or headaches, to detect hyperprolactinemia that can shorten menstrual cycles.

Management and Treatment

Non-Pharmacological Approaches

Non-pharmacological approaches to managing polymenorrhea emphasize and behavioral interventions aimed at stabilizing hormonal fluctuations and supporting overall menstrual . These strategies are often recommended as first-line options, particularly for individuals with mild symptoms or those preferring non-invasive methods, and can help regulate cycle length by addressing underlying factors such as or nutritional deficiencies. Lifestyle modifications play a central role in polymenorrhea . A balanced rich in iron, vitamins (such as B6 and C), and antioxidants supports balance and replenishes nutrients lost during frequent bleeding; for instance, incorporating green leafy vegetables, lean proteins, and fruits can mitigate risks associated with short cycles. Regular moderate exercise, such as walking or swimming for 30 minutes most days, promotes endocrine stability without the disruptions caused by excessive activity, which may shorten cycles further. is also key, as maintaining a (BMI) through and activity helps normalize (GnRH) pulses, with studies showing that even modest in overweight individuals can lengthen menstrual intervals. Stress reduction techniques are essential, given that chronic stress can accelerate GnRH secretion and contribute to shorter cycles. Practices like mindfulness meditation, , or have been shown to lower levels and improve cycle regularity in women with menstrual irregularities. These methods work by modulating the hypothalamic-pituitary-ovarian axis, offering a non-invasive way to restore balance. Cycle tracking using menstrual calendars or mobile applications enables better prediction and management of frequent periods. By logging symptoms, flow duration, and lengths over several months, individuals can identify patterns and optimize sanitary product use, reducing anxiety and improving ; tools like these are endorsed by health organizations for empowering in irregular conditions. Alternative therapies, such as certain herbal supplements, may provide adjunctive support, though evidence is derived from small-scale studies with limited generalizability. Herbal options like (chasteberry) have shown modest efficacy in normalizing cycles and reducing abnormal bleeding frequency in women with , with studies reporting improvement in up to 80% of participants after 3 months of use at 20-40 mg daily; however, results vary, and consultation with a healthcare provider is advised due to potential interactions. Overall, these approaches should complement, not replace, professional evaluation.

Pharmacological and Medical Treatments

According to guidelines from the American College of Obstetricians and Gynecologists (ACOG), management of polymenorrhea focuses on hormonal therapies to regulate cycle length, particularly for ovulatory dysfunction or when no structural cause is identified. Combined oral contraceptives (COCs), containing both estrogen and progestin, suppress ovulation and stabilize the endometrial lining, thereby lengthening cycles to a normal 21-35 day interval in women not seeking pregnancy. Progestin-only pills, taken continuously or in extended regimens, offer a similar mechanism by inducing endometrial atrophy and reducing cycle frequency, particularly useful for those contraindicated for estrogen. The levonorgestrel-releasing intrauterine device (LNG-IUD) provides localized progestin delivery, effectively regulating cycles and reducing bleeding volume by over 90% in many cases of abnormal uterine bleeding, with sustained efficacy for up to 5 years. Treatments targeting specific pathological causes are essential when polymenorrhea stems from identifiable conditions. For hyperthyroidism-induced frequent periods, antithyroid drugs such as methimazole inhibit hormone synthesis, normalizing menstrual cycles by restoring euthyroid status, typically within months of initiation. For ovulatory dysfunction, medications like metformin may improve insulin sensitivity and function, leading to more regular cycles in responsive patients after 6 months of at doses of 500-2000 mg daily. Nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen at 400-600 mg three times daily during menses, alleviate associated and modestly reduce menstrual flow by 25-50%, though they do not directly extend cycle length. Iron supplementation is indicated for anemia secondary to recurrent blood loss from frequent menses. Oral ferrous sulfate, at a standard dose of 325 mg (65 mg elemental iron) once to three times daily, replenishes iron stores and corrects hemoglobin levels, with absorption enhanced when taken on an empty stomach; intravenous iron is reserved for severe or refractory cases. For structural abnormalities contributing to polymenorrhea, surgical interventions may be necessary if medical therapies fail. Myomectomy removes uterine fibroids while preserving fertility, effectively resolving cycle irregularities in symptomatic cases. Polypectomy, often via hysteroscopy, excises endometrial polyps to restore normal cyclicity. In cases with a component of heavy bleeding refractory to medical management, endometrial ablation may be considered to reduce or eliminate menses, though it is not suitable for those desiring future fertility.

Complications and Prognosis

Potential Complications

Untreated polymenorrhea can lead to chronic blood loss, increasing the risk of due to repeated depletion of iron stores. This condition manifests as severe , cognitive impairment from reduced oxygen delivery to the , and potential cardiac in advanced cases, as the heart compensates for lower levels. Frequent menstrual cycles in polymenorrhea may result in unopposed exposure if accompanied by defects or , elevating the risk of . Endometrial hyperplasia involves abnormal thickening of the uterine lining, which can progress to ; studies of women with patterns show a of about 5% for this . Polymenorrhea often stems from an inadequate , where the post-ovulatory period is shortened, potentially hindering implantation and contributing to subfertility, although cycles are not invariably anovulatory. This disruption can impair reproductive outcomes by limiting the window for fertilization, even in ovulating individuals. Beyond physical health risks, polymenorrhea imposes significant quality-of-life burdens, including social disruptions from unpredictable , emotional distress such as anxiety over irregularity, and economic from frequent medical consultations or lost workdays. These impacts can compound noted in associated symptoms, further limiting daily functioning.

Prognosis and Fertility Implications

The prognosis for polymenorrhea is generally favorable when it is physiological, particularly in adolescents and young women, where it often results from an immature hypothalamic-pituitary-ovarian axis and resolves spontaneously within 6-12 months to 2 years as the system matures. In such cases, up to 75% of cycles become ovulatory within 5 years post-menarche, leading to normalization without intervention. For pathological polymenorrhea, outcomes are more variable and depend on the underlying cause, such as endocrine disorders; however, targeted treatments like hormonal therapy often lead to improvement in cycle regularity. , including polymenorrhea, affects 10-30% of reproductive-age women. In adolescents, irregularities, which may include polymenorrhea, are common, affecting up to 75% in the first few years post-menarche due to post-menarcheal irregularities. Regarding fertility implications, polymenorrhea may signal ovulatory dysfunction or defects, which can reduce probabilities by 20-40% compared to women with regular cycles (27-32 days), as evidenced by adjusted fecundability odds ratios of 0.59-0.81 in prospective cohorts. In cases associated with conditions like (PCOS), where short cycles occasionally occur alongside irregular , fertility rates are generally lower (approximately 50% success rate compared to 85% in the general population) without management, though many individuals achieve normal after cycle regulation through or medical interventions. Overall, while polymenorrhea itself does not universally impair , persistent forms warrant evaluation to address potential subfertility risks. Ongoing monitoring is essential, with annual gynecologic examinations recommended to track cycle normalization and screen for complications like from frequent bleeding. During perimenopause, polymenorrhea may transiently emerge due to hormonal fluctuations but typically transitions to irregular or absent post-perimenopause as ovarian function declines.

References

  1. [1]
    Abnormal Vaginal Bleeding - Clinical Methods - NCBI Bookshelf - NIH
    Abnormal vaginal bleeding may occur in association with or independent from menstruation. Bleeding related to the cycle may be abnormal in timing, duration, or ...Missing: treatment | Show results with:treatment
  2. [2]
    Abnormal Uterine Bleeding - StatPearls - NCBI Bookshelf - NIH
    Feb 21, 2025 · Nonhormonal treatment with antifibrinolytic and NSAID medications has been shown to reduce blood loss during menstruation by up to 50%.[8] Oral ...
  3. [3]
    [Hemorrhages in abnormal production of gonadotropins] - PubMed
    Polymenorrhea is usually caused in younger women by a shortening of the proliferation phase, usually because the ovaries are hypersensitive to pituitary ...
  4. [4]
    Women's Wellness: Abnormal menstruation happens in a variety of ...
    Jun 14, 2018 · Bleeding can be heavier (menorrhagia) or lighter (oligomenorrhea) than normal. It can occur too frequently (polymenorrhea) or not frequently ...
  5. [5]
    Polymenorrhea: Treatment, Causes, and How It Affects Pregnancy
    Feb 27, 2018 · Polymenorrhea is a term used to describe a menstrual cycle that is shorter than 21 days. A normal menstrual cycle is between 24 and 38 days long.Polymenorrhea and pregnancy · Causes
  6. [6]
    Menstruation in Girls and Adolescents: Using the Menstrual Cycle as ...
    Environmental factors, including socioeconomic conditions, nutrition, and access to preventive health care, may influence the timing and progression of puberty.Menarche · Abnormal Uterine Bleeding · Evaluation<|control11|><|separator|>
  7. [7]
    Menstrual cycle length and modern living: a review - PMC
    MCL is sensitive to inputs from the environment and varies within and between individuals [2], though a length between 24 and 38 days is considered normal [3].
  8. [8]
    The Menstrual Cycle: Menstruation, Ovulation, and How Pregnancy ...
    The average menstrual cycle lasts about 28 days.
  9. [9]
    Historical Perspectives and Evolution of Menstrual Terminology - PMC
    Feb 28, 2022 · The word “menorrhagia” is derived from the Greek noun “mene” meaning moon, and the verb “regnumi” meaning to burst forth, to let loose or break ...
  10. [10]
    Polymenorrhea: Definition, causes, and treatment
    Feb 24, 2020 · Polymenorrhea describes menstrual cycles that are shorter and more frequent than usual. Read about the causes, symptoms, and treatments ...
  11. [11]
    Prevalence of menstrual problems and their association with ... - NIH
    Polymenorrhea refers to cyclic bleeding that is normal in terms of volume but occurs at too frequent intervals of less than 21 days, for example 5/21.
  12. [12]
    Abnormal Uterine Bleeding - Gynecology and Obstetrics
    Abnormal uterine bleeding (AUB) in patients of reproductive age is a bleeding pattern that is not consistent with normal menstrual cycle parameters.Missing: polymenorrhea | Show results with:polymenorrhea
  13. [13]
    GA20.1 Abnormal frequency of uterine bleeding - ICD-11 MMS
    Frequent menstrual bleeding (GA20.10) · Infrequent menstrual bleeding (GA20.11) · Abnormal frequency of uterine bleeding, unspecified (GA20.1Z).
  14. [14]
    Abnormal Uterine Bleeding In Adolescents - PMC - NIH
    Heavy menstrual bleeding (HMB) is the most frequent clinical presentation of AUB. Anovulatory cycles, owing to immature hypothalamic-pituitary-ovarian axis ...
  15. [15]
    Perimenopause - Symptoms and causes - Mayo Clinic
    the main female hormone in your body — rises and falls. Your periods may get longer or shorter. You may skip ...Missing: decline | Show results with:decline
  16. [16]
    Perimenopause | The Menopause Society
    It's common for cycles to become a little shorter than usual. The number of days of bleeding may be fewer or greater, and blood flow may be heavier or lighter.Missing: shortened decline
  17. [17]
    Menstruation - Your Period While Breastfeeding
    Almost everyone who is fully breastfeeding their babies will be free of menstrual periods for 3 – 6 months or longer. This is called lactational amenorrhea.
  18. [18]
    Predictors of puerperal menstruation - PMC - PubMed Central - NIH
    Jul 10, 2020 · Reports have indicated that there is increasing number of women resuming menstruation within six weeks of childbirth (puerperal menstruation).
  19. [19]
    The Menstrual Disturbances in Endocrine Disorders - NIH
    Oct 14, 2020 · According to available evidence, oligomenorrhea (cycles longer than 35 days) is the most common menstrual disturbance among endocrine disorders.
  20. [20]
    Abnormal Uterine Bleeding | AAFP
    Oct 1, 1999 · Polymenorrhea is usually caused by an inadequate luteal phase or a short follicular phase. Oligomenorrhea in an ovulating woman is usually ...Abstract · History and Physical... · Premenopausal Women<|control11|><|separator|>
  21. [21]
    What are menstrual irregularities? | NICHD
    Jan 31, 2017 · Polymenorrhea (pronounced pol-ee-men-uh-REE-uh): Frequent menstrual periods occurring less than 21 days apart; Irregular menstrual periods ...
  22. [22]
  23. [23]
    Abnormal Uterine Bleeding - AAFP
    Apr 15, 2004 · Potential causes of pregnancy-related bleeding include spontaneous pregnancy loss (miscarriage), ectopic pregnancy, placenta previa, abruptio ...Missing: reliable | Show results with:reliable<|control11|><|separator|>
  24. [24]
    Abnormal Uterine Bleeding: Causes, Diagnosis & Treatment
    Menometrorrhagia is abnormal, unpredictable or irregular uterine bleeding that occurs at any time, not just during menstruation.
  25. [25]
    Ovulation Pain (Mittelschmerz): Causes & Treatment - Cleveland Clinic
    Pain during ovulation occurs when your ovary releases an egg during your menstrual cycle. It causes cramps or aches, usually on one side of your abdomen.
  26. [26]
    The Impact of Irregular Menstruation on Health: A Review of ... - NIH
    Nov 20, 2023 · ... polymenorrhea if the cycle repeats about once every <21 days (>5 pads/day fully soaked); hypomenorrhea if the duration of periods is <2 days ...
  27. [27]
    Premenstrual syndrome (PMS) - Symptoms & causes - Mayo Clinic
    Premenstrual syndrome (PMS) has a wide variety of signs and symptoms, including mood swings, tender breasts, food cravings, fatigue, irritability and ...
  28. [28]
    Abnormal uterine bleeding in nonpregnant reproductive-age patients
    Aug 5, 2025 · Heavy menstrual bleeding · Intermenstrual bleeding · Irregular bleeding · Amenorrhea · Decreased volume · Regular menses with increased frequency.
  29. [29]
    Management of Acute Abnormal Uterine Bleeding in Nonpregnant ...
    Medical management should be the initial treatment for most patients, if clinically appropriate. Options include intravenous conjugated equine estrogen, multi- ...
  30. [30]
    Menstruation Disorders in Adolescents Workup - Medscape Reference
    May 8, 2023 · The laboratory workup for primary amenorrhea depends on the findings from the history and physical examination. If there is physical ...Missing: polymenorrhea | Show results with:polymenorrhea
  31. [31]
    Evaluation and Management of Abnormal Uterine Bleeding ... - AAFP
    Jan 1, 2012 · Following menarche, the immature hypothalamic-pituitary-ovarian axis may result in anovulatory cycles for two to three years. Up to eight ...Missing: polymenorrhea | Show results with:polymenorrhea
  32. [32]
    Endometrial Biopsy: Tips and Pitfalls - AAFP
    May 1, 2020 · Indications. Premenopausal women with abnormal uterine bleeding who are 45 years or older should have an endometrial biopsy performed as a ...Abstract · Indications · Contraindications · Procedure
  33. [33]
    Irregular Periods? Top Lifestyle Changes for Menstrual Health
    Apr 5, 2024 · 1. Follow Dietary Modification · 2. Practice Stress Management · 3. Maintain Healthy Body Weight · 4. Optimize Your Sleep · 5. Look After Gut Health.Missing: frequent | Show results with:frequent
  34. [34]
    Nutrition and Exercise Throughout Your Menstrual Cycle
    Apr 4, 2023 · Iron-rich foods can replace iron lost from bleeding. Examples include green leafy vegetables, lean red meat, lentils and beans. · Vitamin C ...
  35. [35]
    How to Regulate Your Periods: 20 Tips and Tricks - Healthline
    May 8, 2019 · Diet changes · Dietary supplements · Herbal supplements · Healthy weight · Regular exercise · Sleep habits · Stress management · Acupuncture ...
  36. [36]
    How Stress Affects Your Menstrual Cycle | UT Physicians
    May 16, 2025 · Treatment options for irregular menstrual cycles may include simple lifestyle changes. These include adequate nutrition, exercise, good sleep ...
  37. [37]
    Menstrual cycle: What's normal, what's not - Mayo Clinic
    Apr 22, 2023 · You bleed between periods. You develop severe pain during your period. You suddenly get a fever and feel sick after using tampons.
  38. [38]
    Efficacy of acupuncture on menstrual frequency in women with ... - NIH
    A systematic review revealed that there was an improvement in the menstrual frequency of PCOS patients after acupuncture treatment. However, menstrual frequency ...
  39. [39]
    Use of Vitex agnus-castus in patients with menstrual cycle disorders
    Feb 23, 2024 · Improvement in bleeding intensity, frequency and menstrual pain was experienced by 83.4%, 79.2%, and 85.2% of the patients, respectively.
  40. [40]
    General Approaches to Medical Management of Menstrual ... - ACOG
    Gynecologists should be familiar with the use of hormonal therapy for menstrual suppression (including combined oral contraceptive pills, combined hormonal ...Missing: polymenorrhea | Show results with:polymenorrhea
  41. [41]
    Role of Thyroid Dysfunction in Patients with Menstrual Disorders in ...
    Thyroid dysfunction is an important causative etiology of menstrual abnormalities. Assessment of thyroid function should be done in all patients with menstrual ...
  42. [42]
    Is Metformin the Answer for Distressed Females with Menstrual ... - NIH
    Aug 22, 2019 · Monotherapy with metformin is found to be highly effective in treating menstrual irregularities experienced among patients with the polycystic ovarian syndrome.Missing: polymenorrhea | Show results with:polymenorrhea
  43. [43]
    Iron Deficiency Anemia: Evaluation and Management - AAFP
    Jan 15, 2013 · A newer formulation, ferumoxytol, can be given over five minutes and supplies 510 mg of elemental iron per infusion, allowing for greater ...
  44. [44]
    Clinical pattern and spectrum of endometrial pathologies in patients ...
    Nov 5, 2014 · Polymenorrhea was the most common presenting pattern (30%, 72/241) with reproductive age women being the most susceptible (49.3%,119/241).
  45. [45]
    Diagnosis and treatment of luteal phase deficiency: a committee ...
    Luteal phase deficiency (LPD) is a clinical diagnosis associated with an abnormal luteal phase length of %10 days.Progesterone Levels · Endometrial Biopsy · Proposed TreatmentsMissing: postpartum | Show results with:postpartum<|separator|>
  46. [46]
    Effects of short-term and long-term metformin treatment on menstrual ...
    The overall rate of response to met- formin therapy (improvement in menstrual cyclicity) was 69% (95% CI, 0.59–0.77).Missing: outcome polymenorrhea
  47. [47]
    Menstrual cycle characteristics as an indicator of fertility outcomes
    Results show that women with irregular MC length were less likely to achieve conception (FOR irregular = 0.59; 95% CI = 0.45-0.77, P < 0.001).Missing: polymenorrhea | Show results with:polymenorrhea